Skip to content

NIH Websites Are Changing

Beginning in late July, NIH will start introducing a new website experience designed to make it easier to find health information, research, funding opportunities, and other resources. During the transition, you may notice changes to navigation, page layouts, and where some information is located. Learn more in our Frequently Asked Questions.

Gene Editing Technique Improves Vision in Rats with Inherited Blindness

Data Show the New "CRISPR/ Cas9" System Potentially Can Be Used to Prevent Retinal Damage in a Type of Retinitis Pigmentosa, One of the Most Common Inherited Disorders of the Retina
January 7, 2016
Blindness Gene Therapy Genetics Rare Diseases Retinitis Pigmentosa
Translational Research
Grantee

A new technique that has the potential to treat inherited diseases by removing genetic defects has been shown for the first time to hinder retinitis pigmentosa, a degenerative eye disease with no known cure that can lead to blindness. A research team at the Cedars-Sinai Board of Governors Regenerative Medicine Institute used a technique known as CRISPR/Cas9 to remove a genetic mutation that causes the blindness disease. The study was published in the journal Molecular Therapy.

Read more at Cedars Sinai News
Back to top